OPKO Health, Inc. Payments to Acquire Marketable Securities
OPKO Health, Inc. (OPK) reported Payments to Acquire Marketable Securities of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2025-10-29
- OPKO Health, Inc. payments to acquire marketable securities for the quarter ending 2019-03-31 was $0.00.
- OPKO Health, Inc. payments to acquire marketable securities for the quarter ending 2018-12-31 was $0.00.
- OPKO Health, Inc. payments to acquire marketable securities for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. payments to acquire marketable securities for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. payments to acquire marketable securities for fiscal 2018 was $0.00.
- OPKO Health, Inc. payments to acquire marketable securities for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- OPKO Health, Inc. payments to acquire marketable securities for fiscal 2016 was $15.64M.
- OPKO Health, Inc. payments to acquire marketable securities for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-10-29 | |||
| 2024-09-30 | $1.45M 10-Q · filed 2025-10-29 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-05-08 | $0.00 derived: sum of 3 quarters · filed 2019-05-08 | $0.00 derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | -$6.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | -$6.00K derived: sum of 3 quarters · filed 2019-05-08 | -$5.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | -$6.00K derived: sum of 2 quarters · filed 2019-05-08 | -$5.00K derived: sum of 3 quarters · filed 2019-05-08 | $0.00 derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$5.00K derived: sum of 2 quarters · filed 2019-03-01 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 |
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $6.00K derived: sum of 2 quarters · filed 2018-11-09 | $6.00K 10-Q · filed 2018-11-09 | $19.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $5.00K 10-Q · filed 2018-08-07 | $18.00K derived: sum of 3 quarters · filed 2019-03-01 | $19.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $13.00K derived: sum of 2 quarters · filed 2019-03-01 | $14.00K derived: sum of 3 quarters · filed 2019-03-01 | $15.64M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $14.00K derived: sum of 2 quarters · filed 2019-03-01 | $15.64M derived: sum of 3 quarters · filed 2019-03-01 | $15.64M 10-K · filed 2019-03-01 |
| 2016-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $15.63M derived: sum of 2 quarters · filed 2017-11-08 | $15.63M 10-Q · filed 2017-11-08 | $15.63M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | $15.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $15.63M 10-Q · filed 2017-08-08 | $15.63M derived: sum of 3 quarters · filed 2019-01-29 | $15.63M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-01-29 | $0.00 derived: sum of 3 quarters · filed 2019-01-29 | |
| 2015-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $0.00 derived: sum of 2 quarters · filed 2019-01-29 | $0.00 8-K · filed 2019-01-29 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-08 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $50.03M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $50.03M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $50.03M 10-Q · filed 2014-08-11 | |||
| 2012-12-31 | -$3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $8.69M derived: sum of 2 quarters · filed 2015-02-27 | $10.81M derived: sum of 3 quarters · filed 2015-02-27 | $25.81M 10-K · filed 2015-02-27 |
| 2012-09-30 | $11.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $13.93M derived: sum of 2 quarters · filed 2013-11-12 | $28.92M 10-Q · filed 2013-11-12 | $28.92M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $17.12M 10-Q · filed 2013-08-09 | $17.12M derived: sum of 3 quarters · filed 2014-03-03 | $47.30M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $15.00M 10-Q · filed 2013-05-10 | $15.00M derived: sum of 2 quarters · filed 2014-03-03 | $45.18M derived: sum of 3 quarters · filed 2014-03-03 | $55.17M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $30.18M derived: sum of 2 quarters · filed 2014-03-03 | $40.18M derived: sum of 3 quarters · filed 2014-03-03 | $100.16M 10-K · filed 2014-03-03 |
| 2011-09-30 | $30.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $40.18M derived: sum of 2 quarters · filed 2012-11-09 | $100.16M 10-Q · filed 2012-11-09 | $100.16M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $69.98M 10-Q · filed 2012-08-09 | $69.98M derived: sum of 3 quarters · filed 2013-03-18 | $69.98M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $59.98M 10-Q · filed 2012-05-10 | $59.98M derived: sum of 2 quarters · filed 2013-03-18 | $59.98M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $15.00M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $15.00M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $15.00M 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $10.00M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |